PMDA drug package insert
フェアストン錠40
PMDA Prescription drug · 日本化薬株式会社 · package insert Jun 2, 2025
Key facts
| Brand names | フェアストン錠40 |
|---|---|
| Nonproprietary names | トレミフェンクエン酸塩 |
| Companies | 製造販売元／日本化薬株式会社, 提携先／Orion Corporation, Finland |
| Product type | Prescription drug |
| Therapeutic category | 乳癌治療剤 |
| Therapeutic category codes | 874291 |
| YJ codes | 4291007F1021 |
| Approval numbers | 20700AMY00113 |
| Package insert edition | 第2版 |
| Package insert date | Jun 2, 2025 |
| PMDA document key | 530191_4291007F1021_1 |
| PMDA company code | 530191 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: